Cargando…
Evolution of coreceptor utilization to escape CCR5 antagonist therapy
The HIV-1 envelope interacts with coreceptors CCR5 and CXCR4 in a dynamic, multi-step process, its molecular details not clearly delineated. Use of CCR5 antagonists results in tropism shift and therapeutic failure. Here we describe a novel approach using full-length patient-derived gp160 quasispecie...
Autores principales: | Zhang, Jie, Gao, Xiang, Martin, John, Rosa, Bruce, Chen, Zheng, Mitreva, Makedonka, Henrich, Timothy, Kuritzkes, Daniel, Ratner, Lee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913893/ https://www.ncbi.nlm.nih.gov/pubmed/27128349 http://dx.doi.org/10.1016/j.virol.2016.04.010 |
Ejemplares similares
-
Evolution of Multiple Domains of the HIV-1 Envelope Glycoprotein during Coreceptor Switch with CCR5 Antagonist Therapy
por: Du, Yueqi, et al.
Publicado: (2022) -
Endocytosis and Recycling of the HIV Coreceptor Ccr5
por: Signoret, Nathalie, et al.
Publicado: (2000) -
Resistance to the CCR5 Inhibitor 5P12-RANTES Requires a Difficult Evolution from CCR5 to CXCR4 Coreceptor Use
por: Nedellec, Rebecca, et al.
Publicado: (2011) -
Quantitative Deep Sequencing Reveals Dynamic HIV-1 Escape and Large Population Shifts during CCR5 Antagonist Therapy In Vivo
por: Tsibris, Athe M. N., et al.
Publicado: (2009) -
Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African populations
por: Picton, Anabela C.P., et al.
Publicado: (2010)